Global T Cell Therapy Market to Hit US$ 9,035.01 Million by 2030
T cell therapy is a personalized immunotherapy approach that modifies a patient’s own immune cells to precisely identify and attack diseased cells. By enhancing the natural cancer fighting ability of T lymphocytes, it offers targeted treatment with the potential for long term remission. This innovative strategy represents a significant shift from conventional therapies toward highly...
0 Comments 0 Shares 52 Views